Exact Mass: 683.2730326000001
Exact Mass Matches: 683.2730326000001
Found 42 metabolites which its exact mass value is equals to given mass value 683.2730326000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
27-O-Demethylrifamycin SV
A member of the class of rifamycins that is rifamycin SV lacking the O-methyl group at position 27. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins
1??-Nicotinoyloxy-2??-acetoxy-6??-acetoxy-9??-furoyloxy-11-(2-methyl)butyryloxy-4??-hydroxydihydro-??-agarofuran
(1R,2S,3S,4S,5R,7R,9S,10R)-2-acetoxy-9-benzoyloxy-1-cinnamoyloxy-3-nicotinoyloxy-4-hydroxydihydro-beta-agarofuran
C39H41NO10 (683.2730326000001)
2,2,7,7-Tetrabromo-9,9-spirobifluorene
C31H37N7O9S (683.2373352000001)
Chaxamycin D
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins
N-[(3R,9R,10R)-9-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide
N-[(3S,9S,10S)-9-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide
2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,29,30-trioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,25-heptaen-13-yl acetate
12-(acetyloxy)-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-6-{[(2-methylbutanoyl)oxy]methyl}-4-(2-oxopropyl)-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate
(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,21z)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,29,30-trioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,25-heptaen-13-yl acetate
(1s,2s,4r,5s,6r,7s,9r,12r)-12-(acetyloxy)-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-6-({[(2r)-2-methylbutanoyl]oxy}methyl)-4-(2-oxopropyl)-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate
[(2r,3r,3as,4s,4as,5s,8r,8as,9r,10as)-3,5,9-tris(acetyloxy)-4-(butanoyloxy)-10a-hydroxy-2,9-dimethyl-10-oxo-8-(prop-1-en-2-yl)-1h,2h,3h,3ah,4h,5h,8h,8ah-cyclohexa[f]azulen-4a-yl]methyl pyridine-3-carboxylate
[3,5,9-tris(acetyloxy)-4-(butanoyloxy)-10a-hydroxy-2,9-dimethyl-10-oxo-8-(prop-1-en-2-yl)-1h,2h,3h,3ah,4h,5h,8h,8ah-cyclohexa[f]azulen-4a-yl]methyl pyridine-3-carboxylate
(6s,7r,9e,11s,12r,13r,14r,15r,16r,17s,18s)-2,6,11,15,17,23-hexahydroxy-3,7,12,14,16,18,26-heptamethyl-27,29-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,23,25-octaen-13-yl acetate
2-[2-(2-{2-[(1s)-1-{[(2e)-1-hydroxy-2-(methoxyimino)-3-methylbutylidene]amino}-2-methylpropyl]-1,3-oxazol-4-yl}-5-methyl-1,3-oxazol-4-yl)-1,3-thiazol-4-yl]-n-[(2s,3s)-1-methoxy-3-methyl-1-oxopentan-2-yl]-5-methyl-1,3-oxazole-4-carboximidic acid
(6s,7r,9e,11r,12s,13s,14s,15s,16s,17r,18r,19e,21z)-2,6,11,15,17,23-hexahydroxy-3,7,12,14,16,18,26-heptamethyl-27,29-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,23,25-octaen-13-yl acetate
(6s,7r,9e,11s,12r,13r,14r,15r,16r,17s,18s,19e,21z)-2,6,11,15,17,23-hexahydroxy-3,7,12,14,16,18,26-heptamethyl-27,29-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,23,25-octaen-13-yl acetate
2,6,11,15,17-pentahydroxy-3,7,12,14,16,18,26-heptamethyl-23,27,29-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,25-heptaen-13-yl acetate
(1r,2r,4s,5s,7r,8s,9r,11r,12s,13r,14r,17s,18s)-4,18-bis(acetyloxy)-13-(benzoyloxy)-7-formyl-17-hydroxy-7,10-dimethyl-15-methylidene-10-azahexacyclo[7.7.1.1²,¹⁴.0¹,¹².0³,⁸.0³,¹¹]octadecan-5-yl benzoate
C39H41NO10 (683.2730326000001)
2-[2-(2-{2-[(1s)-1-{[(2z)-1-hydroxy-2-(methoxyimino)-3-methylbutylidene]amino}-2-methylpropyl]-1,3-oxazol-4-yl}-5-methyl-1,3-oxazol-4-yl)-1,3-thiazol-4-yl]-n-[(2s,3s)-1-methoxy-3-methyl-1-oxopentan-2-yl]-5-methyl-1,3-oxazole-4-carboximidic acid
n-(1-methoxy-3-methyl-1-oxopentan-2-yl)-2-{2-[2-(2-{1-[2-(methoxyimino)-3-methylbutanamido]-2-methylpropyl}-1,3-oxazol-4-yl)-5-methyl-1,3-oxazol-4-yl]-1,3-thiazol-4-yl}-5-methyl-1,3-oxazole-4-carboximidic acid
(1r,2r,3s,4s,5s,7r,8s,9r,11r,12s,13r,14r,17s,18s)-4,18-bis(acetyloxy)-13-(benzoyloxy)-7-formyl-17-hydroxy-7,10-dimethyl-15-methylidene-10-azahexacyclo[7.7.1.1²,¹⁴.0¹,¹².0³,⁸.0³,¹¹]octadecan-5-yl benzoate
C39H41NO10 (683.2730326000001)